Please sign in to follow a disease.

Ureter neoplasm

MONDO:0021111

A benign or malignant neoplasm that affects the ureter.

Also known as: neoplasm of the ureter, neoplasm of ureter, neoplasms of the ureter, neoplasms of ureter, tumor of the ureter, tumor of ureter, tumour of the ureter, tumour of ureter

1468 clinical trials for this condition and its sub-types, 2 tagged with Ureter neoplasm itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Urinary system neoplasm (1694) ↑ Ureteral disorder (95)

Sub-types of Ureter neoplasm

Ureter cancer 27 trials · 34 incl. sub-types
3 sub-types
- Ureter carcinoma 1 trial · 19 incl. sub-types Sub-types →
- Ureteral lymphoma 0 trials
- Ureteric orifice cancer 0 trials
Ureter benign neoplasm 1 trial
3 sub-types
- Schwannoma of ureter 0 trials
- Ureter leiomyoma 0 trials
- Ureter urothelial papilloma 0 trials Sub-types →
Polyp of ureter 0 trials

Most studied deeper sub-types

Ureter transitional cell carcinoma (16) Infiltrating ureter transitional cell carcinoma (1) Ureter adenocarcinoma (1) Ureter small cell carcinoma (1) Ureter squamous cell carcinoma (1) Carcinoma in situ of ureter (0) Regional ureteric cancer (0) Ureter inverted papilloma (0)

Including sub-types (1468) Tagged with Ureter neoplasm (2)

Trials to join now! 1 Terminated 1

New drug LOXO-435 targets Hard-to-Treat bladder cancers

Disease control Recruiting now

This early-stage trial is testing a new oral drug called LOXO-435, alone or with other cancer medicines, in people with advanced solid tumors that have a specific change in the FGFR3 gene. The study aims to find the right dose and check for safety and early signs of effectiveness…

Phase 1 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated Aug 22, 2026 00:00 UTC

Ureter neoplasm

Where it sits in the disease tree

Most studied deeper sub-types

New drug LOXO-435 targets Hard-to-Treat bladder cancers